Considering gene therapy to protect from X-linked deafness DFNX2 and associated neurodevelopmental disorders
{{output}}
Mutations and deletions in the gene or upstream of the gene encoding the POU3F4 transcription factor cause X-linked progressive deafness DFNX2 and additional neurodevelopmental disorders in humans. Hearing loss can be purely sensorineural or mixed, that is, wi... ...
